Gérard, A. O., Gérard, A. O., Gérard, A. O., Merino, D., Merino, D., Benzaquen, J., . . . Sicard, A. PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: Analysis of the WHO pharmacovigilance database. Frontiers Media S.A.
Chicago Style (17th ed.) CitationGérard, Alexandre O., et al. PDL1 Inhibitors May Be Associated with a Lower Risk of Allograft Rejection than PD1 and CTLA4 Inhibitors: Analysis of the WHO Pharmacovigilance Database. Frontiers Media S.A.
MLA (9th ed.) CitationGérard, Alexandre O., et al. PDL1 Inhibitors May Be Associated with a Lower Risk of Allograft Rejection than PD1 and CTLA4 Inhibitors: Analysis of the WHO Pharmacovigilance Database. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.